New hope for duchenne: Long-Term drug trial aims to slow muscle decline
NCT ID NCT07573631
First seen May 09, 2026 · Last updated May 12, 2026 · Updated 1 time
Summary
This study looks at the long-term safety and effects of a weekly infusion called BMN 351 in people with Duchenne muscular dystrophy (DMD) who can benefit from exon 51 skipping. Participants must have completed a previous BMN 351 study and stay on a stable steroid dose. The goal is to see if the drug helps maintain physical function over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DUCHENE MUSCULAR DYSTROPHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fondazione Serena ETS - Centro Clinico NeMO Milano
Milan, Italy
-
Great Ormond Street Hospital NHS Foundation Trust
London, WC1N 3JH, United Kingdom
-
Hospital Sant Joan de Deu
Barcelona, 08950, Spain
-
Hospital Viamed Santa Angela De la Cruz
Seville, 41013, Spain
-
Leids Universitair Medisch Centrum
Leiden, 2333 ZA, Netherlands
-
UOC Fase I - Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore
Rome, Italy
-
Yeditepe University Kosuyolu Hospital
Istanbul, Turkey, Turkey (Türkiye)
Conditions
Explore the condition pages connected to this study.